These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

105 related items for PubMed ID: 24878819

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6. Na+/H+ exchanger regulatory factor 1 expression levels in blood and tissue predict breast tumour clinical behaviour.
    Bellizzi A, Mangia A, Malfettone A, Cardone RA, Simone G, Reshkin SJ, Paradiso A.
    Histopathology; 2011 Jun; 58(7):1086-95. PubMed ID: 21707710
    [Abstract] [Full Text] [Related]

  • 7. NHERF1/EBP50 head-to-tail intramolecular interaction masks association with PDZ domain ligands.
    Morales FC, Takahashi Y, Momin S, Adams H, Chen X, Georgescu MM.
    Mol Cell Biol; 2007 Apr; 27(7):2527-37. PubMed ID: 17242191
    [Abstract] [Full Text] [Related]

  • 8. The NHERF1 PDZ2 domain regulates PKA-RhoA-p38-mediated NHE1 activation and invasion in breast tumor cells.
    Cardone RA, Bellizzi A, Busco G, Weinman EJ, Dell'Aquila ME, Casavola V, Azzariti A, Mangia A, Paradiso A, Reshkin SJ.
    Mol Biol Cell; 2007 May; 18(5):1768-80. PubMed ID: 17332506
    [Abstract] [Full Text] [Related]

  • 9. Gene expression profiling of luminal B breast cancers reveals NHERF1 as a new marker of endocrine resistance.
    Karn T, Ruckhäberle E, Hanker L, Müller V, Schmidt M, Solbach C, Gätje R, Gehrmann M, Holtrich U, Kaufmann M, Rody A.
    Breast Cancer Res Treat; 2011 Nov; 130(2):409-20. PubMed ID: 21203899
    [Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11. β-catenin interaction with NHERF1 and RASSF1A methylation in metastatic colorectal cancer patients.
    Schirosi L, Mazzotta A, Opinto G, Pinto R, Graziano G, Tommasi S, Fucci L, Simone G, Mangia A.
    Oncotarget; 2016 Oct 18; 7(42):67841-67850. PubMed ID: 27765918
    [Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13. Repressing of NHERF1 inhibits liver cancer progression by promoting the production of ROS.
    Sun J, Li P, Yang J.
    Biochem Biophys Res Commun; 2019 Jan 29; 509(1):8-15. PubMed ID: 30581004
    [Abstract] [Full Text] [Related]

  • 14. A Novel NHERF1 Mutation in Human Breast Cancer Inactivates Inhibition by NHERF1 Protein in EGFR Signaling.
    DU G, Hao C, Gu Y, Wang Z, Jiang WG, He J, Cheng S.
    Anticancer Res; 2016 Mar 29; 36(3):1165-73. PubMed ID: 26977012
    [Abstract] [Full Text] [Related]

  • 15. NHERF1 regulates the progression of colorectal cancer through the interplay with VEGFR2 pathway.
    Gu Y, Yu H, Hao C, Martin TA, Hargest R, He J, Cheng S, Jiang WG.
    Oncotarget; 2017 Jan 31; 8(5):7753-7765. PubMed ID: 27999191
    [Abstract] [Full Text] [Related]

  • 16. Na+/H+ exchanger regulatory factor 1 inhibits platelet-derived growth factor signaling in breast cancer cells.
    Pan Y, Weinman EJ, Dai JL.
    Breast Cancer Res; 2008 Jan 31; 10(1):R5. PubMed ID: 18190691
    [Abstract] [Full Text] [Related]

  • 17. NHERF1, a novel GPER associated protein, increases stability and activation of GPER in ER-positive breast cancer.
    Meng R, Qin Q, Xiong Y, Wang Y, Zheng J, Zhao Y, Tao T, Wang Q, Liu H, Wang S, Jiang WG, He J.
    Oncotarget; 2016 Aug 23; 7(34):54983-54997. PubMed ID: 27448983
    [Abstract] [Full Text] [Related]

  • 18. Overexpression of nuclear NHERF1 in advanced colorectal cancer: association with hypoxic microenvironment and tumor invasive phenotype.
    Malfettone A, Silvestris N, Paradiso A, Mattioli E, Simone G, Mangia A.
    Exp Mol Pathol; 2012 Jun 23; 92(3):296-303. PubMed ID: 22440733
    [Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20. Expression of Na+/H+ exchanger regulatory factor 1 in autosomal-dominant polycystic kidney disease.
    Wang JQ, Qin F, Zhu L.
    J Int Med Res; 2015 Oct 23; 43(5):629-38. PubMed ID: 26142394
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 6.